title: The management of nausea and vomiting of pregnancy and hyperemesis gravidarum--a 2013 update.
abstract: Nausea and vomiting of pregnancy (NVP) affects up to 85% of all pregnancies, yet many physicians are uncertain as to how to best treat their patients in the presence of controversial data on fetal risks. This review provides an update on the management of NVP, including pharmacological and non pharmacological approaches Due to a high rate of recurrent symptoms, it is important for women to receive early treatment to reduce the severity of symptoms with the aim of preventing hospitalization and improving quality of life.
authors.affiliation: Motherisk Program, Division of Clinical Pharmacology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Caroline
authors.initials: C
authors.lastname: Maltepe
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D005260:Female; D006760:Hospitalization; D006801:Humans; D006939:Hyperemesis Gravidarum / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D048968:Morning Sickness / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D011247:Pregnancy; D011788:Quality of Life; D012008:Recurrence; D012720:Severity of Illness Index
chemical_list: D000932:Antiemetics